HEALTH

Dec 21 2024HEALTH

Hormone Therapy and Breast Cancer: What Women Think

Women going through postmenopause and suffering from early-stage breast cancer often rely on hormone therapy (HT) to delay cancer's return. But HT comes with side effects that can take a toll on their overall well-being. There's a way to make it better, though. A mix of exercise and health education

reading time less than a minute
Dec 21 2024HEALTH

Exploring How Fermented Lentils and Quinoa Change Older Adults' Gut Bacteria

As plant-based foods gain popularity, scientists are exploring new ways to make them even better. One recent study focused on fermented lentils and quinoa flour, which could offer older adults a protein boost. The researchers wanted to see how these foods affect the gut bacteria of older adults. The

reading time less than a minute
Dec 21 2024HEALTH

Can Chemo After Surgery Really Help Biliary Cancer Patients?

Biliary tract cancers are known for their high recurrence rates, even after successful surgery. This makes the future look quite grim for those diagnosed. One common approach to reduce this recurrence risk is to use adjuvant chemotherapy (ACT) after surgery. ACT aims to target and destroy any tiny c

reading time less than a minute
Dec 21 2024HEALTH

Global Shifts in Biliary Tract Cancer Deaths, 2000-2022: A Worldwide Analysis

Biliary tract cancers (BTCs), like intrahepatic cholangiocarcinoma (iCCA), extrahepatic cholangiocarcinoma (eCCA), gallbladder cancer (GBC), and ampullary cancer, are tough to beat. Researchers looked at how death rates from these cancers changed over time. They checked out data from the World Healt

reading time less than a minute
Dec 21 2024HEALTH

New Hope for Advanced Biliary Tract Cancer: Combining Nivolumab with Chemotherapy

Advanced biliary tract cancer (BTC) is a tough nut to crack. Doctors often turn to second-line treatments like 5-fluorouracil (5FU) and liposomal irinotecan when first-line therapies fail. These drugs have shown promise in improving survival rates. But what if we could make them even more effective?

reading time less than a minute
Dec 21 2024HEALTH

Is Better Housing the Key to Slimming Down with Age?

Housing might seem like a far-off worry when it comes to staying fit as we age. But a fresh look into older adults' lives in China and India shows that the quality of your home could play a big part in keeping muscles strong. Researchers are starting to ask: can better housing help fight sarcopenia,

reading time less than a minute
Dec 21 2024HEALTH

Unusual Virus Strains Strike Pakistani Poultry

Infectious bursal disease, a nasty virus threatening the global poultry industry, is causing big trouble in Pakistan. This study dives into the unique characteristics of the viruses in the Faisalabad district. By examining the VP2 gene, which plays a key role in the virus, scientists discovered that

reading time less than a minute
Dec 21 2024HEALTH

School Enrollment After ACTH Therapy for Infantile Epilepsy Patients

Infantile epileptic spasms syndrome (IESS) can lead to serious brain development issues. But how does this affect kids' chances of going to elementary school? This study looked into that, focusing on kids who got adrenocorticotropic hormone (ACTH) therapy. ACTH therapy is a common treatment for IES

reading time less than a minute
Dec 21 2024HEALTH

Managing Leg Stump Growth: A New Technique for Young Injury Patients

Stump overgrowth is a common challenge for kids who've lost a limb before their bones are fully grown. Doctors have tried various methods to stop this, but they don't always work. A new approach is making waves: shortening the tibia (one of the lower leg bones) beforehand to keep the stump from grow

reading time less than a minute
Dec 21 2024HEALTH

Immunotherapy Combo for Kidney Cancer: Real-World Results

Let's talk about a powerful duo in the fight against advanced kidney cancer. Nivolumab and ipilimumab, often called NIVO + IPI, are like the dynamic duo of immunotherapy. They're used to treat people with intermediate- or high-risk advanced or metastatic renal cell carcinoma (mRCC). Now, you might b

reading time less than a minute